• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatocellular Carcinoma Arising Adjacent to Antiphospholipid Syndrome-associated Hepatic Infarction in a Non-cirrhotic Liver.非肝硬化肝脏中抗磷脂综合征相关肝梗死旁发生的肝细胞癌
Intern Med. 2025 Oct 1;64(19):2839-2845. doi: 10.2169/internalmedicine.5081-24. Epub 2025 Mar 22.
2
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.特瑞普利单抗联合肝动脉灌注化疗与仑伐替尼治疗晚期肝细胞癌的比较
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211063848. doi: 10.1177/15330338211063848.
3
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.肿瘤成纤维细胞生长因子受体4水平可预测晚期肝细胞癌患者使用乐伐替尼的疗效。
Clin Transl Gastroenterol. 2020 May;11(5):e00179. doi: 10.14309/ctg.0000000000000179.
4
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.经动脉化疗栓塞联合乐伐替尼加帕博利珠单抗与双重安慰剂治疗不可切除、非转移性肝细胞癌(LEAP-012):一项多中心、随机、双盲、3期研究
Lancet. 2025 Jan 18;405(10474):203-215. doi: 10.1016/S0140-6736(24)02575-3. Epub 2025 Jan 8.
5
[A case of advanced hepatocellular carcinoma wherein readministration was made possible due to successful transcatheter arterial embolization for intratumoral hemorrhage during Lenvatinib administration].
Nihon Shokakibyo Gakkai Zasshi. 2022;119(5):476-485. doi: 10.11405/nisshoshi.119.476.
6
Diagnosis of liver infarction postpartum.产后肝梗死的诊断。
Obstet Gynecol. 2005 May;105(5 Pt 2):1271-3. doi: 10.1097/01.AOG.0000159656.69166.ff.
7
Repeated courses of transarterial embolization with polyvinyl alcohol particles: 'long life elixir' in a cirrhotic patient with unresectable hepatocellular carcinoma.经动脉用聚乙烯醇颗粒反复进行栓塞治疗:一位无法切除的肝细胞癌肝硬化患者的“长生不老药”
Eur J Gastroenterol Hepatol. 2007 Apr;19(4):329-32. doi: 10.1097/MEG.0b013e3280298391.
8
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma.早期仑伐替尼治疗的相对剂量强度对肝细胞癌治疗反应的影响。
Anticancer Res. 2019 Sep;39(9):5149-5156. doi: 10.21873/anticanres.13710.
9
Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report.两名患者均患有巨大肝细胞癌和门静脉侵犯,在两次转换后接受肝移植:病例报告。
World J Gastroenterol. 2024 Sep 28;30(36):4071-4077. doi: 10.3748/wjg.v30.i36.4071.
10
Surgical resection of vascular-invasive late-stage hepatocellular carcinoma following transarterial chemoembolization combined with lenvatinib and tislelizumab: Two case reports and literature review.经动脉化疗栓塞联合乐伐替尼和替雷利珠单抗治疗后对血管侵犯性晚期肝细胞癌进行手术切除:两例报告及文献综述
Medicine (Baltimore). 2025 Jun 20;104(25):e42973. doi: 10.1097/MD.0000000000042973.

本文引用的文献

1
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare vascular pathology, part II.WFUMB CEUS 肝脏指南的评论和说明:罕见血管病变,第二部分。
Med Ultrason. 2023 Jun 26;25(2):189-200. doi: 10.11152/mu-4013.
2
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
3
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).肝细胞癌临床实践指南:日本肝脏学会2021版(第5版JSH-HCC指南)
Hepatol Res. 2023 May;53(5):383-390. doi: 10.1111/hepr.13892. Epub 2023 Mar 10.
4
Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature.严重指端缺血与恶性肿瘤相关抗磷脂综合征中的血小板减少症并存:一例报告及文献复习
World J Clin Cases. 2021 Dec 26;9(36):11457-11466. doi: 10.12998/wjcc.v9.i36.11457.
5
Hypoxia sensing by hepatic stellate cells leads to VEGF-dependent angiogenesis and may contribute to accelerated liver regeneration.肝星状细胞的缺氧感应导致血管内皮生长因子依赖性血管生成,可能有助于加速肝脏再生。
Sci Rep. 2020 Mar 9;10(1):4392. doi: 10.1038/s41598-020-60709-9.
6
Antiphospholipid antibodies and antiphospholipid syndrome in cancer: Uninvited guests in troubled times.抗磷脂抗体与癌症相关的抗磷脂抗体综合征:多事之秋的不速之客。
Semin Cancer Biol. 2020 Aug;64:108-113. doi: 10.1016/j.semcancer.2019.07.019. Epub 2019 Jul 24.
7
Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.系统性红斑狼疮继发抗磷脂综合征所致肝梗死
J Rheumatol. 2019 Jul;46(7):755-756. doi: 10.3899/jrheum.181241.
8
Spontaneous Hepatic Infarction in a Patient with Gallbladder Cancer.一名胆囊癌患者的自发性肝梗死
Case Rep Oncol. 2016 Jun 14;9(2):321-7. doi: 10.1159/000446911. eCollection 2016 May-Aug.
9
Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.布加综合征相关肝细胞癌:韩国单中心长期随访经验
World J Gastroenterol. 2012 Apr 28;18(16):1946-52. doi: 10.3748/wjg.v18.i16.1946.
10
A large asymptomatic hepatic mass.
Liver Int. 2012 Jan;32(1):78. doi: 10.1111/j.1478-3231.2011.02622.x. Epub 2011 Aug 9.

非肝硬化肝脏中抗磷脂综合征相关肝梗死旁发生的肝细胞癌

Hepatocellular Carcinoma Arising Adjacent to Antiphospholipid Syndrome-associated Hepatic Infarction in a Non-cirrhotic Liver.

作者信息

Kusumi Yuriko, Hasebe Takumu, Hayashi Manami, Kamikokura Yuki, Otake Shin, Hayashi Hidemi, Ota Yu, Nakajima Shunsuke, Aso Kazunobu, Sawada Koji, Tanino Mishie, Fujiya Mikihiro

机构信息

Department of Internal Medicine, Division of Gastroenterology, Asahikawa Medical University, Japan.

Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Japan.

出版信息

Intern Med. 2025 Oct 1;64(19):2839-2845. doi: 10.2169/internalmedicine.5081-24. Epub 2025 Mar 22.

DOI:10.2169/internalmedicine.5081-24
PMID:40128996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12549042/
Abstract

A man in his 70s with antiphospholipid syndrome (APS) presented with a hepatic mass. Initial imaging suggested hepatic infarction, as the liver tumor markers were normal, and coagulation tests indicated a hypercoagulable state. Three years later, follow-up imaging revealed tumor enlargement, leading to a biopsy-confirmed hepatocellular carcinoma diagnosis. Transarterial embolization was performed followed by lenvatinib therapy. The patient achieved complete response with no recurrence for over eight months. This case highlights the potential of APS to contribute to liver carcinogenesis in non-cirrhotic patients and illustrates the need for individualized treatment strategies.

摘要

一名70多岁的抗磷脂综合征(APS)男性患者出现肝脏肿块。初始影像学检查提示肝梗死,因为肝脏肿瘤标志物正常,凝血检查显示高凝状态。三年后,随访影像学检查显示肿瘤增大,活检确诊为肝细胞癌。进行了经动脉栓塞术,随后采用乐伐替尼治疗。患者实现完全缓解,超过八个月无复发。该病例突出了APS在非肝硬化患者肝脏致癌中的潜在作用,并说明了个性化治疗策略的必要性。